Celiac Disease (CD)-Market Insights, Epidemiology and Market Forecast-2023

Publisher Name :
Date: 01-Nov-2017
No. of pages: 67
Delivery of the Report will take 2-3 working days once order is placed.

DelveInsight's "Celiac Disease (CD)- Market Insights, Epidemiology and Market Forecast-2023" report provides an overview of the disease and global market size of the Celiac Disease for the 6MM (United States and EU5 countries (France, Germany, Italy, Spain and UK)). It also includes global historical and forecasted epidemiological data for the diagnosed prevalent cases of Celiac Disease from 2013-2023.

Celiac disease is a genetic autoimmune disease where the indigestion of gluten leads to damage in the small intestine. The number of ways celiac disease can affect patients, combined with a lack of training in medical schools and primary care residency programs, contributes to the poor diagnosis rate. Currently it is estimated that 80% of the celiac disease population remains undiagnosed. Prevalence in Western Europe and in the United States ranges between 1 in 250 and 1 in 133. It is higher in relatives of people with celiac disease. Women are affected more commonly than men, but there is no age predilection. DelveInsight forecasts predict that the total prevalent cases of Celiac Disease is expected to accentuate up to 4.69 Million by 2023 at a Compound Annual Growth Rate (CAGR) of 0.46% from 2013-2023 while the diagnosed prevalent population of Celiac Disease in the 6MM shall grow at a CAGR of 0.15% for the forecast period (2013-2023).

There is no targeted therapy approved for celiac disease. The current standard of care treatment involves a gluten free diet (GFD). Steroids and immunosuppressants are used to reduce symptoms in severe cases. Owing to the expected launch of Larazotide Acetate (Innovate Pharmaceuticals) in 2021 followed by the launch of Latiglutenase (ImmunogenX/Abbvie) in 2023, shall lead to a hike in the otherwise stable, worldwide market size of celiac disease. DelveInsight estimates suggest that the global market size is expected to grow at a CAGR of 19% from 2013-2023.

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house Forecast model analysis by Publisher team of industry experts.

Scope

- Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.

- It focuses on the detailed historical and forecasted number of total prevalent cases as well as diagnosed prevalent cases of Celiac Disease for 6MM from 2013-2023.

- The Report also includes historical and forecasted Market size of Celiac Disease for 6MM from 2013 to 2023.

- It provides the information of available marketed therapies, including off-label biologics, patent and exclusivity details.

- The report also focuses on the details of pipeline drugs in the pivotal stage of development including their SWOT Analysis and expected launch date, which shall help to predict the impact of those drugs on the market size in the near future.

Celiac Disease (CD)-Market Insights, Epidemiology and Market Forecast-2023

Table of Contents

Report Introduction
Celiac Disease Market Size Overview at a Glance
Worldwide Market Size of Celiac Disease in 2013
Worldwide Market Size of Celiac Disease in 2023
Celiac Disease Overview
Celiac Disease Types
Non-Responsive or Refractory CD
Etiology
Symptoms
Diagnosis
Disease Management
Disease Treatment
Treatment of Celiac Disease
Treatment of Non-Responsive or Refractory Celiac Disease (RCD)
Current Unmet Medical Needs
Epidemiology Parameters
Iceberg Model
Genetic Predisposition
Epidemiology &Patient Population
United States
Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
EU5 Countries
France
Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Germany
Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Italy
Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Spain
Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
United Kingdom
Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Emerging Phase III Therapies
Larazotide acetate
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Latiglutenase
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
AMG 714
Product Description
Regulatory Milestones
Clinical Development
Clinical Pipeline Activity
Clinical Trial by Phase
SWOT Analysis
Celiac Disease Market Size
Global Market Size of Celiac Disease (2013-2023)
Region-Wise Market size of Celiac Disease (2013-2023)
United States
Total Market Size of Celiac Disease (2013-2023)
European Five Countries
Italy
Total Market Size of Celiac Disease (2013-2023)
Germany
Total Market Size of Celiac Disease (2013-2023)
France
Total Market Size of Celiac Disease(2013-2023)
United Kingdom
Total Market Size of Celiac Disease (2013-2023)
Spain
Total Market Size of Celiac Disease (2013-2023)
Japan- Epidemiology and Market Size
Market Drivers
Market Barriers
Appendix
Report Methodology
Consulting Services
Disclaimer
About DelveInsight

List of Tables

Table 1:Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Table 2:Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Table 3:Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Table 4:Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Table 5:Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Table 6:Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Table 7: Larazotide acetate, Clinical Trials by Zone, 2017
Table 8: Latiglutenase, Clinical Trials by Zone, 2017
Table 9: AMG 714, Clinical Trials by Zone, 2017
Table 11: Total Market size of Celiac Diseasein USD, Million(2013-2023)
Table 12: Total Market size of Celiac Disease (Region-Wise) in USD, Million(2013-2023)
Table 13: US market size of Celiac Diseasein USD, Million(2013-2023)
Table 14: Italy market size of Celiac Diseasein USD, Million(2013-2023)
Table 15: Germany market size of Celiac Disease in USD, Million(2013-2023)
Table 16: France market size of Celiac Diseasein USD, Million(2013-2023)
Table 17: United Kingdom market size of Celiac Diseasein USD, Million(2013-2023)
Table 18:Spain market size of Celiac Disease in USD, Million(2013-2023)

List of Figures

Figure 1: Diagnosed Prevalent Cases of Celiac Disease in United States (2013-2023)
Figure 2: Diagnosed Prevalent Cases of Celiac Disease in France (2013-2023)
Figure 3: Diagnosed Prevalent Cases of Celiac Disease in Germany (2013-2023)
Figure 4: Diagnosed Prevalent Cases of Celiac Disease in Italy (2013-2023)
Figure 5: Diagnosed Prevalent Cases of Celiac Disease in Spain (2013-2023)
Figure 6: Diagnosed Prevalent Cases of Celiac Disease in United Kingdom (2013-2023)
Figure 7: Larazotide acetate, Clinical Trials by Zone (%), 2017
Figure 8: Latiglutenase, Clinical Trials by Zone (%), 2017
Figure 9: AMG 714, Clinical Trials by Zone (%), 2017
Figure 11: Total Market Size of Celiac Disease in USD, Million(2013-2023)
Figure 11: Region-Wise Market size of Celiac Disease in USD, Million(2013-2023)
Figure 13: US Market Size of Celiac Disease in USD, Million(2013-2023)
Figure 14: Italy market size of Celiac Disease in USD, Million(2013-2023)
Figure 15: Germany market size of Celiac Disease in USD, Million (2013-2023)
Figure 16: France market size of Celiac Disease in USD, Million(2013-2023)
Figure 17: United Kingdom market size of Celiac Disease in USD, Million(2013-2023)
Figure 18: Spain market size of Celiac Disease in USD, Million(2013-2023)
  • Global Gastrointestinal Drugs Market Size, Status and Forecast 2025
    Published: 10-Jan-2018        Price: US 3300 Onwards        Pages: 92
    This report studies the global Gastrointestinal Drugs market, analyzes and researches the Gastrointestinal Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Abbott Laboratories - Allergan - AstraZeneca - Bayer - Boehringer Ingelheim - GlaxoSmithKline - Janssen Biotech - Sanofi - Takeda Pharmaceutical - Valeant Phar......
  • Global Anti Peptic Ulcer Drugs Market Size, Status and Forecast 2025
    Published: 10-Jan-2018        Price: US 3300 Onwards        Pages: 104
    This report studies the global Anti Peptic Ulcer Drugs market, analyzes and researches the Anti Peptic Ulcer Drugs development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like - Eisai - Daewoong Pharmaceutical - Takeda Pharmaceutical - HeliCure - AstraZeneca - Ore Pharmaceuticals - Sihuan Pharmaceutical - GlaxoSmithKline - Pfizer - A......
  • Global Irritable Bowel Syndrome (IBS) Market Research Report 2011-2023
    Published: 04-Jan-2018        Price: US 1870 Onwards        Pages: 84
    Summary Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled internat......
  • Global Laxatives Market Professional Survey Report 2017
    Published: 04-Jan-2018        Price: US 3500 Onwards        Pages: 100
    This report studies Laxatives in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AstraZeneca plc - Boehringer Ingelheim GmbH - Bayer AG - GlaxoSmithKline......
  • Global Laxatives Market Professional Survey Report 2018
    Published: 01-Jan-2018        Price: US 3500 Onwards        Pages: 100
    This report studies Laxatives in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering - AstraZeneca plc - Boehringer Ingelheim GmbH - Bayer AG - GlaxoSmithKline......
  • Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 80
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Failure (Hepatic Insufficiency) - Pipeline Review, H2 2017, provides an overview of the Liver Failure (Hepatic Insufficiency) (Gastrointestinal) pipeline landscape. Liver failure is severe deterioration of liver function. Liver failure occurs when a large portion of the liver is damaged due to any type of liver disorder. Symptoms may include jaundice, tendency to bruise or bleed easily, asci......
  • Exocrine Pancreatic Insufficiency - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 44
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Exocrine Pancreatic Insufficiency - Pipeline Review, H2 2017, provides an overview of the Exocrine Pancreatic Insufficiency (Gastrointestinal) pipeline landscape. Exocrine pancreatic insufficiency (EPI) is a condition characterized by deficiency of the exocrine pancreatic enzymes, resulting in the inability to digest food properly, or maldigestion. Symptoms include diarrhea, loose, oily stools with......
  • Short Bowel Syndrome - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 54
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Short Bowel Syndrome - Pipeline Review, H2 2017, provides an overview of the Short Bowel Syndrome (Gastrointestinal) pipeline landscape. Short bowel syndrome is a complex disease that occurs due to the physical loss or the loss of function of a portion of the small and/or large intestine. Symptoms include bloating, cramping, fatigue, heartburn, vomiting, weakness and diarrhea. Complications of shor......
  • Peptic Ulcers - Pipeline Review, H2 2017
    Published: 29-Dec-2017        Price: US 2000 Onwards        Pages: 54
    Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Peptic Ulcers - Pipeline Review, H2 2017, provides an overview of the Peptic Ulcers (Gastrointestinal) pipeline landscape. Peptic ulcers are open sores that develop on the inside lining of esophagus, stomach and the upper portion of small intestine. Symptoms include nausea or vomiting, unexplained weight loss, appetite changes and abdominal pain. Risk factors include smoking and alcoholism. Treatme......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs